Qube Research & Technologies (QRT)’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
VPM
VCM
B
Qube Research & Technologies (QRT)'s NEO Position: Q1 2026 in Review
Qube Research & Technologies (QRT) opened a new position in NeoGenomics (NEO) in Q1 2026: 65,571 shares worth $487K. The stake represents ﹤0.01% of the portfolio and ranks #2743 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in NEO as recently as Q2 2025.
Qube Research & Technologies (QRT) first reported a position in NEO in Q4 2019 and has held it in 12 quarters since. The position peaked at $1.73M in Q3 2023. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.
- Qube Research & Technologies (QRT) held 65,571 shares of NeoGenomics worth $487K as of Q1 2026.
- NeoGenomics was a new Qube Research & Technologies (QRT) position in Q1 2026.
- NeoGenomics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2743 holding.
- Qube Research & Technologies (QRT) first reported a position in NeoGenomics in Q4 2019 and has held it in 12 quarters since.
- Qube Research & Technologies (QRT)'s NeoGenomics position peaked at $1.73M in Q3 2023.
- 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.